Tender

Consultancy work to evaluate the all-Wales Suspected Cancer Pathway (SCP) Programme

  • NHS Wales Shared Services Partnership

F02: Contract notice

Notice identifier: 2023/S 000-016823

Procurement identifier (OCID): ocds-h6vhtk-03d605

Published 14 June 2023, 11:08am



Section one: Contracting authority

one.1) Name and addresses

NHS Wales Shared Services Partnership

2nd Floor Woodland House, Maes-y-Coed Road

Cardiff

CF14 4TT

Email

Nia.Miles@wales.nhs.uk

Telephone

+44 2921508271

Country

United Kingdom

NUTS code

UK - United Kingdom

Internet address(es)

Main address

http://www.procurement.wales.nhs.uk

Buyer's address

http://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221

one.2) Information about joint procurement

The contract is awarded by a central purchasing body

one.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at

https://etenderwales.bravosolution.co.uk/home.html

Additional information can be obtained from the above-mentioned address

Tenders or requests to participate must be submitted electronically via

http://NWSSP.Cardiff.Procurement@wales.nhs.uk

one.4) Type of the contracting authority

Regional or local authority

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Consultancy work to evaluate the all-Wales Suspected Cancer Pathway (SCP) Programme

Reference number

CAV-ITT-PROJECT53738

two.1.2) Main CPV code

  • 79419000 - Evaluation consultancy services

two.1.3) Type of contract

Services

two.1.4) Short description

NHS Procurement Wales, on behalf of the NHS Executive, Wales Cancer Network, wishes to invite proposals for the evaluation of the all-Wales Suspected Cancer Programme (SCP) programme.

The 3-year Suspected Cancer Pathway (SCP) Programme was introduced in April 2021, as a national programme to support NHS organisations to transform their cancer patient pathways through a whole system approach. The programme was intended to provide a platform for innovation across the diagnostic and treatment intervals of the patient pathway by developing a suite of National Optimal Pathways (NOPs). The NOPs are designed to align with the metric of the Suspected Cancer Pathway, and describe the optimal steps, sequence and associated timings along the patient cancer pathway, including all diagnostic steps, investigations and treatments. The SCP programme aims to deliver the vision of the NOPs aligned to the metric of the SCP to achieve better outcomes and experience for cancer patients across Wales.

We require a robust and independent assessment of the impact of the SCP programme.

The following key programme deliverables were identified:

· To review, develop and publish the National Optimal Pathways.

· In partnership with cancer Multidisciplinary Teams support the implement of the National Optimal Pathways through a whole-system approach.

· Support health boards to improve SCP performance (Point of Suspicion to First Definitive Treatment).

· Deliver the programme through a Value Based Health Care approach, to achieve better outcomes and experiences for cancer patients.

· Work collaboratively with health boards and stakeholders to share learning from the programme activities.

Programme aim and objectives

Aim:

· To enable effective implementation of the SCP across Wales, through a whole system approach informed by business intelligence data.

Objectives:

· To support health boards/trust in Wales to implement the SCP performance target (Point of Suspicion to First Definitive Treatment within 62 days) aligned to the best practice principles described by the National Optimal Pathways.

· To work in partnership with cancer MDTs to embed the vision of the National Optimal Pathways.

To support Health Boards/ Trust to implement data driven service improvements across the National Optimal Pathways

two.1.5) Estimated total value

Value excluding VAT: £100,000

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.2) Additional CPV code(s)

  • 79419000 - Evaluation consultancy services

two.2.3) Place of performance

NUTS codes
  • UKL22 - Cardiff and Vale of Glamorgan
Main site or place of performance

NHS Collaborative - Cardiff

two.2.4) Description of the procurement

NHS Procurement Wales, on behalf of the NHS Executive, Wales Cancer Network, wishes to invite proposals for the evaluation of the all-Wales Suspected Cancer Programme (SCP) programme.

The 3-year Suspected Cancer Pathway (SCP) Programme was introduced in April 2021, as a national programme to support NHS organisations to transform their cancer patient pathways through a whole system approach. The programme was intended to provide a platform for innovation across the diagnostic and treatment intervals of the patient pathway by developing a suite of National Optimal Pathways (NOPs). The NOPs are designed to align with the metric of the Suspected Cancer Pathway, and describe the optimal steps, sequence and associated timings along the patient cancer pathway, including all diagnostic steps, investigations and treatments. The SCP programme aims to deliver the vision of the NOPs aligned to the metric of the SCP to achieve better outcomes and experience for cancer patients across Wales.

We require a robust and independent assessment of the impact of the SCP programme.

The following key programme deliverables were identified:

· To review, develop and publish the National Optimal Pathways.

· In partnership with cancer Multidisciplinary Teams support the implement of the National Optimal Pathways through a whole-system approach.

· Support health boards to improve SCP performance (Point of Suspicion to First Definitive Treatment).

· Deliver the programme through a Value Based Health Care approach, to achieve better outcomes and experiences for cancer patients.

· Work collaboratively with health boards and stakeholders to share learning from the programme activities.

Programme aim and objectives

Aim:

· To enable effective implementation of the SCP across Wales, through a whole system approach informed by business intelligence data.

Objectives:

· To support health boards/trust in Wales to implement the SCP performance target (Point of Suspicion to First Definitive Treatment within 62 days) aligned to the best practice principles described by the National Optimal Pathways.

· To work in partnership with cancer MDTs to embed the vision of the National Optimal Pathways.

To support Health Boards/ Trust to implement data driven service improvements across the National Optimal Pathways

two.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

two.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

6

This contract is subject to renewal

No

two.2.10) Information about variants

Variants will be accepted: No

two.2.11) Information about options

Options: No

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section three. Legal, economic, financial and technical information

three.1) Conditions for participation

three.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

List and brief description of conditions

Details can be found within the tender documents. The documents can be obtained from eTender Wales Bravo Solutionas

three.1.2) Economic and financial standing

Selection criteria as stated in the procurement documents

three.1.3) Technical and professional ability

Selection criteria as stated in the procurement documents

three.2) Conditions related to the contract

three.2.1) Information about a particular profession

Execution of the service is reserved to a particular profession

three.2.2) Contract performance conditions

As stated within the ITT

three.2.3) Information about staff responsible for the performance of the contract

Obligation to indicate the names and professional qualifications of the staff assigned to performing the contract


Section four. Procedure

four.1) Description

four.1.1) Type of procedure

Open procedure

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

four.2) Administrative information

four.2.2) Time limit for receipt of tenders or requests to participate

Date

4 July 2023

Local time

12:00pm

four.2.4) Languages in which tenders or requests to participate may be submitted

English

four.2.7) Conditions for opening of tenders

Date

4 July 2023

Local time

12:00pm


Section six. Complementary information

six.1) Information about recurrence

This is a recurrent procurement: No

six.3) Additional information

Please note additional information on this procurement:

1. The Contracting Authority reserves the right to award the contract in whole, in part or annul the tendering process and not award

contract.

2. Bidders should note that they will be required to enter into terms and conditions of contract as set out in the ITT and that save for matters

of clarification or consistency the Contracting Authority will not negotiate the terms.

3. The Contracting Authority will not accept completed ITT's after the stated closing date.

4. All documents to be priced (where applicable) in sterling and all payments made in sterling.

5. All tender costs and liabilities incurred by bidders shall be the sole responsibility of the bidders.

6. In reference to II.1.9 (Variants) to the extent permitted, if at all, in the tender documents.

7. Prospective suppliers should note that NHS Shared Services Partnership - Procurement Services is acting on behalf of Cardiff and Vale

ULHB.

NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at

http://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=65818.

NOTE: The authority is using eTenderwales to carry out this procurement process. To obtain further information record your interest on

Sell2Wales at http://www.sell2wales.gov.wales/search/search_switch.aspx?ID=68368

(WA Ref:68368)

The Health Board will ensure that this procurement process, which is being undertaken in accordance with the Open Procedure, pursuant to and as defined in the Public Contracts Regulations 2015 (as amended) Light Touch Regime.

NOTE: The authority is using eTenderwales to carry out this procurement process. To obtain further information record your interest on Sell2Wales at https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=132373

(WA Ref:132373)

six.4) Procedures for review

six.4.1) Review body

High Court

Royal Courts of Justice, The Strand

London

WC2A 2LL

Country

United Kingdom

Internet address

http://www.procurement.wales.nhs.uk